Shukur, H.Y. 2020. Long term continuous Trastuzumab use for HER2-positive advanced breast cancer. Journal of Contemporary Medical Sciences. 6, 5 (Oct. 2020), 234–241. DOI:https://doi.org/10.22317/jcms.v6i5.862.